Far Too Few People of Color in U.S. Pancreatic Cancer Trials
WEDNESDAY, Aug. 18, 2021 (HealthDay News) — Racial and ethnic minorities in the United States are severely underrepresented in clinical trials testing cutting-edge treatments for pancreatic cancer, researchers say. “There are a ton of obstacles to get these patients into clinical trials,” said senior author Dr. Jose Trevino, chairman ofContinue Reading